En 7 día(s), 7 hora(s) y 51 minuto(s): El Repositorio Institucional UNAL informa a la comunidad universitaria que, con motivo del periodo de vacaciones colectivas, el servicio de publicación estará suspendido: Periodo de cierre: Del 20 de diciembre al 18 de enero de 2026. Sobre los depósitos: Durante este tiempo, los usuarios podrán continuar realizando el depósito respectivo de sus trabajos en la plataforma. Reanudación: Una vez reiniciadas las actividades administrativas, los documentos serán revisados y publicados en orden de llegada.

Contribución al desarrollo de una formulación líquida de administración oral para un extracto de hojas de Passiflora quadrangularis L aplicando los conceptos del enfoque de calidad basada en el diseño (QbD)

dc.contributor.advisorBaena Aristizábal, Yolimaspa
dc.contributor.authorPorras Gaviria, David Orlandospa
dc.contributor.researchgroupGRUPO DE INVESTIGACIÓN EN TECNOLOGÍA DE PRODUCTOS NATURALES - TECPRONAspa
dc.date.accessioned2020-03-09T13:09:20Zspa
dc.date.available2020-03-09T13:09:20Zspa
dc.date.issued2019-07-20spa
dc.description.abstractObjectives previously defined are the starting point of Quality by design (QbD) to ensure the quality, safety and efficacy of the product. This research was focused on the exemplifies of some QbD principles in the development of a liquid formulation from a hydroalcoholic extract of leaves of Passiflora quadrangularis, specifically those that affect the formulation proposal and the manufacturing process. In the first stage Target Product Profile, Quality Target Product Profile and Critical Quality Attributes were determined through interviews to health professionals and reviewing the scientific literature. This information guided the other process stages. In the preformulation tests, the effect of temperature, light, ethanol concentration and the effect of a polyol on response variables such as pH, color, amount of precipitate and quantification of markers was evaluated. Light was the only variable having a statistically significant effect on stability of the extract. The antimicrobial efficacy test demonstrates the self-preserved capacity of P. quadrangularis. This information will propose a prototype formulation and the corresponding manufacturing process, our risk analysis (RAM Matrix and FMEA matrix) will facilitate the design of proposals regarding control strategies.spa
dc.description.abstractEl enfoque de calidad basado en el diseño (QbD) tiene como punto de partida unos objetivos previamente definidos que permiten asegurar la calidad, seguridad y eficacia del producto. El presente trabajo de investigación ejemplifica la implementación de algunos principios de QbD en el desarrollo de una formulación líquida a partir de un extracto hidroalcohólico de hojas de Passiflora quadrangularis, específicamente aquellos que aplican hasta la propuesta de la formulación y del proceso de fabricación. En su primera fase se determinó el perfil del producto, el perfil de calidad del producto y los atributos críticos de calidad, mediante entrevista a profesionales de la salud y revisión de la literatura científica. Esta información orientó las demás etapas del trabajo. Así, en los ensayos de preformulación se evaluó el efecto de la temperatura, la luz, la concentración de etanol y el tipo de poliol sobre variables respuesta como pH, color, cantidad de precipitado y cuantificación de marcadores. La luz fue la única variable que tuvo un efecto estadísticamente significativo sobre la estabilidad del extracto. La prueba de eficacia antimicrobiana evidenció la capacidad de autopreservación del extracto de P. quadrangularis. Esta información permitió proponer un prototipo de formulación y el proceso de fabricación correspondiente, cuyo análisis del riesgo (matriz RAM y matriz FMEA) facilitó el diseño de propuestas respecto a las estrategias de control.spa
dc.description.additionalMagíster en Ciencias Farmacéuticas. Línea de Investigación: Diseño y desarrollo de productos fitofarmacéuticosspa
dc.description.degreelevelMaestríaspa
dc.description.projectRed Nacional para la Bioprospección de Frutas Tropicales RIFRUTBIOspa
dc.description.sponsorshipCOLCIENCIASspa
dc.format.extent135spa
dc.format.mimetypeapplication/pdfspa
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/75969
dc.language.isospaspa
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotáspa
dc.publisher.departmentDepartamento de Farmaciaspa
dc.relation.referencesAtanasov AG, Waltenberger BA, Pferschy EM, Linder TD, Wawrosch CA, Uhrin PS, et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol. Adv. 2015;33(8):1582–1614.spa
dc.relation.referencesRather MA, Bhat BA, Qurishi MA. Multicomponent phytotherapeutic approach gaining momentum: Is the “one drug to fit all” model breaking down?. Phytomedicine. 2013;21(1):1–14.spa
dc.relation.referencesBruno D, Wolfender JL, Dias DA. The pharmaceutical industry and natural products: historical status and new trends. Phytochem Rev. 2014;14(2):299–315.spa
dc.relation.referencesCragg GM, Newman DJ. Natural products: A continuing source of novel drug leads. Biochim. Biophys. Acta. 2013;1830(6):3670–3695.spa
dc.relation.referencesRocha H, Cuadro J, Mora C. Aplicación de la calidad basada en el diseño (QbD) en la reformulación de tabletas masticables. Rev. colomb. cienc. quim. farm. 2013;42(2):190–214.spa
dc.relation.referencesISPE. Concepts and Principles SPE Guide Series: PQLI® from Concept to Continual Improvement Product Realization using Quality by Design (QbD). Part 1 Product Realization using Quality by Design (QbD): Concepts and Principles. 2011: 11–39.spa
dc.relation.referencesJanssen W. The Story of the Laws Behind the Label. 1th. ed. United States of America: FDA; 1962.spa
dc.relation.referencesPonce LF, Rodríguez A. Buenas Prácticas de Manufactura Vigentes y su relación con la Garantia De Calidad. Rev. colomb. cienc. quim. farm. 1992;20: 63–68.spa
dc.relation.referencesCharoo NA, Shamsher AAA, Zidan AS, Rahman Z. Quality by design approach for formulation development: A case study of dispersible tablets. Int. J. Pharm. 2012;423(2):167–178.spa
dc.relation.referencesWorld Health Organization. Expert Committee on Specifications for Pharmaceutical Preparations. WHO Technical Report Series. Geneve. 1992;24-35.spa
dc.relation.referencesMora CE. “Nuevos enfoques” de las Buenas Prácticas de Manufactura. Rev. colomb. cienc. quim. farm. 2009;38(1):42–58.spa
dc.relation.referencesGarcía OF, Vallejo BM, Mora CE. La calidad desde el diseño: principios y oportunidades para la industria farmacéutica. Estud.Gerenc. 2015;31(134):68–78.spa
dc.relation.referencesWelch KA, Fung CA, Schmidt SS. Risk/Science-based approach to validation: A win-win-win for patients, regulators, and industry. Pharm. Sci. Technol. 2004;58(45):15–23.spa
dc.relation.referencesZhang L, Mao S. Applications of quality by design (QbD) and its tools in drug delivery. Asian J. Pharm. 2016;11(1):144–155.spa
dc.relation.referencesPatel GM, Shelat PK, Lalwani AN. QbD based development of proliposome of lopinavir for improved oral bioavailability. Eur. J. Pharm. Sci. 2016;9(4):225-248spa
dc.relation.referencesMhatre R, Rathore A. Quality by design: an overview of the basic concepts. Quality by Design for Biopharmaceuticals. John Wiley & Sons. 2009.spa
dc.relation.referencesYan B, Li Y, Guo Z, Qu H. Quality by design for herbal drugs: A feedforward control strategy and an approach to define the acceptable ranges of critical quality attributes. Phytochem. Anal. 2014;25(1):59–65.spa
dc.relation.referencesUhlenbrock L, Sixt M, Tegtmeier M, Schulz H, Hagels H, Ditz R, et al. Natural products extraction of the future sustainable manufacturing solutions for societal needs. Processes. 2018;6(10):2-28.spa
dc.relation.referencesKroll U, Cordes C. Pharmaceutical prerequisites for a multi-target therapy. Phytomedicine. 2006;13(2):12–19.spa
dc.relation.referencesYousef SA, Mohammed YH, Namjoshi S, Grice JE, Benson HAE, Sakran W, et al. Mechanistic evaluation of enhanced curcumin delivery through human skin in vitro from optimised nanoemulsion formulations fabricated with different penetration enhancers. Pharmaceutics. 2019;11(12):2-20.spa
dc.relation.referencesCarriço C, Pinto P, Graça A, Gonçalves LM, Ribeiro HM, Marto J. Design and characterization of a new quercus suber based pickering emulsion for topical application. Pharmaceutics. 2019;11(3):1–16.spa
dc.relation.referencesThakur D, Jain A, Ghoshal G, Shivhare US, Katare OP. RP-HPLC method development using analytical QbD approach for estimation of cyanidin-3-O-glucoside in natural biopolymer based microcapsules and tablet dosage form. J Pharm. Investig. 2017;47(5):413–427.spa
dc.relation.referencesSharma R, Kamboj S, Khurana R, Singh G, Rana V. Physicochemical and functional performance of pectin extracted by QbD approach from Tamarindus indica L. pulp. Carbohydr. Polym. 2015;134:364–374.spa
dc.relation.referencesOrganización Mundial para la Salud. Salud mental: Fortalecer nuestra respuesta. Colombia. 2016.spa
dc.relation.referencesMinisterio de Salud y Protección Social. Guía de manejo para trastornos de ansiedad. Colombia. 2014;1–47.spa
dc.relation.referencesMinisterio de Salud y Protección Social. Encuesta Nacional de Salud Mental 2015. Colombia. Tomo I. 2015.spa
dc.relation.referencesLópez F, Álamo C, García P. The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: Half a century of anxiolytic drugs. J. Anxiety Disord. 2011;25(4):554–562.spa
dc.relation.referencesLópez C, Estrada E. Mexican medicinal plants with anxiolytic or antidepressant activity: Focus on preclinical research. J. Ethnopharmacol. 2016;186:377–391.spa
dc.relation.referencesAjao MY, Akindele AJ. Anxiolytic and sedative properties of hydroethanolic extract of Telfairia occidentalis leaves in mice. Rev. bras. farmacogn. 2013;23(2):301–309.spa
dc.relation.referencesKetcha GJM, Djiogue S, Gamo FZ, Ngitedem SG, Njamen D. Anxiolytic and sedative activities of aqueous leaf extract of Dichrocephala integrifolia (Asteraceae) in mice. J. Ethnopharmacol. 2015;176:494–508.spa
dc.relation.referencesÁvila G, González ME, Carballo AI, Aguilar B, García S, Giles DE, et al. Anxiolytic-like effects and toxicological studies of Brickellia cavanillesii (Cass.) A. Gray in experimental mice models. J. Ethnopharmacol. 2016;192:90–98.spa
dc.relation.referencesKhan IN, Sarker MMI, Ajrin M. Sedative and anxiolytic effects of ethanolic extract of Calotropis gigantea (Asclepiadaceae) leaves. Asian Pac J Trop Biomed. 2014;4:400-404.spa
dc.relation.referencesKebebew Z, Shibeshi W. Evaluation of anxiolytic and sedative effects of 80% ethanolic Carica papaya L. (Caricaceae) pulp extract in mice. J. Ethnopharmacol. 2013;150(2):665–671.spa
dc.relation.referencesNwosu MO. Herbs for mental disorders. Fitoterapia. 1999;70:58–63.spa
dc.relation.referencesSollozo I, Estrada E, Carro M, López C. GABAA/benzodiazepine receptor complex mediates the anxiolytic-like effect of Montanoa tomentosa. J. Ethnopharmacol. 2015;162:278–286.spa
dc.relation.referencesSandoval MD. Huila es potencia mundial en Passifloras. El Espectador.2013.spa
dc.relation.referencesMinisterio de Agricultura y Desarrollo Rural. Sistema de información de gestión y desempeño de organizaciones de cadenas. Retrieved. 2015.spa
dc.relation.referencesBarrios L. "Estudios de la diversidad de Passifloreacea en los departamentos de Caldas, Choco,Nariño, Quindio, Risaralda y Valle del Cauca (Colombia), Apoyados en los análisis ecogeográficos, palinológicos y citogenéticos" Tesis de Maestría. Universidad Nacional de Colombia; 2005: 38-59.spa
dc.relation.referencesDhawan K, Dhawan S, Sharma A. Passiflora: A review update. J. Ethnopharmacol. 2004;94(1):1–23.spa
dc.relation.referencesMedina HI. "Aporte al diseño de un sistema microparticulado para un extracto de Passiflora quadrangularis Linn" Tesis de Maestría. Universidad Nacional de Colombia; 2014:30-75.spa
dc.relation.referencesHanada S. Pharmacological Trials of Crude Extract of Passiflora alata. Planta Medica. New York. Georg Thieme Verlag Stuttgart. 1984;303–316.spa
dc.relation.referencesHickey M, King C. 100 Families of Flowering Plants. United Kingdom. Cambridge Univ Press. 1988;130–153.spa
dc.relation.referencesFelter HW, Lloyd J. King’s American Dispensatory. The plants. United State. Eighteenth edition 1898;89-112spa
dc.relation.referencesChopra RN, Nayar SL, Chopra I. Glossary of Indian Medicinal Plants. India. 1956;186–187.spa
dc.relation.referencesSeaforth CE, Adams CD, Sylvester Y. A Guide for the Medicinal Plants of Trinidad & Tobago. Commonw Secreteriate, Marlbrgh House, Pall Mall. 1983;95-102.spa
dc.relation.referencesBergner P. Passionflower. “Aust. J. Medical Herbal. 7;13–24.spa
dc.relation.referencesDomínguez LF. "Evaluación cualitativa de la solubilidad de flavonoides presentes en un extracto de hojas de Passiflora quadrangularis" Tesis de Grado. Universidad Nacional de Colombia; 2016:20-45.spa
dc.relation.referencesOsorio C, Duque C, Fujimoto Y. Oxygenated monoterpenoids from badea (Passiflora quadrangularis) fruit pulp. Phytochemistry. 2000;53(1):97–101.spa
dc.relation.referencesGazola AC. Flavonoid constituents of Passiflora quadrangularis Linneaus leaves aqueous extract and the in vivo sedative activity through GABAergic pathway. J Ethnopharmacol. 2015;100–125.spa
dc.relation.referencesAvallone R, Zanoli P, Puia G, Kleinschnitz M, Schreier P, Baraldi M. Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla. Biochem. Pharmacol. 2000;59(11):1387–1394.spa
dc.relation.referencesGazola AC, Costa GM, Castellanos L, Ramos F a., Reginatto FH, Lima TCM De, et al. Involvement of GABAergic pathway in the sedative activity of apigenin, the main flavonoid from Passiflora quadrangularis pericarp. Rev. bras. farmacogn. 2015;25(2):158–163.spa
dc.relation.referencesPorras D. "Estudio para la evaluación de la compatibilidad entre un extracto de Passiflora quadrangularis y algunos excipientes" Tesis de Grado. Universidad Nacional De Colombia 2016:2–16.spa
dc.relation.referencesEcheverry S. "Aporte a la estandarización del proceso de obtención de un extracto de hojas de Passiflora quadrangularis" Tesis de Maestría. Universidad Nacional de Colombia; 2017:16-58.spa
dc.relation.referencesHerrera J, Cardenas P. "Contribución al estudio de la estabilidad de 6-metilcumarina libre y microencapsulada" Tesis de grado. Universidad Nacional de Colombia; 2016:10-19.spa
dc.relation.referencesConvención farmacopeica de los Estados Unidos. Prueba de eficacia antimicrobiana. Farmacopea de los Estados Unidos de América 38. 2015:1034-1038.spa
dc.relation.referencesMaguire J, Peng D, Ostrove S, Brindle A, Davy S, Tiffany D, et al. Risk Analysis and Mitigation Matrix (RAMM) – A Risk Tool for Quality Management. FDA 2nd Conf. 2011;32(1):1–19.spa
dc.relation.referencesCarbone TA, Tippett DD. Project risk management using the project risk FMEA. Eng Manag J. 2004;16(4):28–35.spa
dc.relation.referencesPramod K, Tahir MA, Charoo NA, Ansari SH, Ali J. Pharmaceutical product development : A quality by design approach. Int J Pharm Investig. 2016;24(9):129-140.spa
dc.relation.referencesFDA. Target Product Profile a Strategic Development Guidance for Industry and Review Staff Target Product Profile. Guidance for Industry and Review Staff. FDA Guidance. 2007;13.-14.spa
dc.relation.referencesGutiérrez SL, Chilpa RR, Jahms HB. Medicinal plants for the treatment of “nervios”, anxiety, and depression in Mexican Traditional Medicine. Rev. bras. farmacogn. 2014;24(5):591–608.spa
dc.relation.referencesSaffari M, Ebrahimi A, Langrish T. A novel formulation for solubility and content uniformity enhancement of poorly water-soluble drugs using highly-porous mannitol. Eur J Pharm Sci. 2016;83:52–61.spa
dc.relation.referencesMelo JG, Santos AG, De Amorim EL. Medicinal plants used as antitumor agents in Brazil: An ethnobotanical approach. Evid-Based Compl Alt. 2011;5:2-8.spa
dc.relation.referencesBrantley S, Argikar A, Lin. Y, Nagar S, Paine M. Herb-drug interactions: Challenges and opportunities for improved predictions. Drug Metab Dispos. 2014;42(3):301–317.spa
dc.relation.referencesBarnes PM, Powell-griner E, Mcfann K, Nahin RL. Complementary and Alternative Medicine Use Among Adults: United States 2002. Res. Integr. Med. 2004;5:54-63spa
dc.relation.referencesKhan IA. Issues related to botanicals. Life Sci. 2006;78(18):2033–2038.spa
dc.relation.referencesCosta D, Ulbricht C, Chao W, Weissner W, Rusie-Seamon E, Woods J. Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration. Curr. Drug Metab. 2008;9(10):1063–1120.spa
dc.relation.referencesVillas GR, Stefanello AP, Feitosa BC, Lima CA, Arce E, Oesterreich SA. The ethanolic extract obtained from Campomanesia pubescens (D.C.) O.BERG fruits exerts anxiolytic and antidepressant effects on chronic mild stress model and on anxiety models in Wistar rats: Behavioral evidences. Nutr Neurosci. 2018;7(2):1–11.spa
dc.relation.referencesAkhondzadeh S, Naghavi HV. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001;26:363–367.spa
dc.relation.referencesMovafegh A, Alizadeh R, Hajimohamadi F, Esfehani F, Nejatfar M. Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients: A double-blind, placebo-controlled study. Anesth Analg. 2008;106(6):1728–1732.spa
dc.relation.referencesSchulz H, Jobert M, Hübner WD. The quantitative EEG as a screening instrument to identify sedative effects of single doses of plant extracts in comparison with diazepam. Phytomedicine. 1998;5(6):449–458.spa
dc.relation.referencesNgan A, Conduit R. A Double-blind , Placebo‐controlled Investigation of the Effects of Passiflora incarnata ( Passionflower) Herbal Tea on Subjective Sleep Quality. Phytother. Res. 2011;11:1153–1159.spa
dc.relation.referencesBourin M, Bougerol T, Guitton B, Broutin E. A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: Controlled study versus placebo. Fundam Clin Pharmacol. 1997;11(2):127–132.spa
dc.relation.referencesGonzález L. "Passiflora en el tratamiento de la ansiedad y el insomnio" Tesis Doctorado. Universidad Complutense; 2017;25-115.spa
dc.relation.referencesINVIMA. Sistema de Tramites en Línea - Consultas Públicas [Internet]. [cited 2019 Jun 17].spa
dc.relation.referencesMéndez G, Fuentes VR, Soler BA, Villanueva G, Lemes Hernández GM, Rodríguez A. Variación de índices farmacognósticos en Passiflora incarnata L. con la época y hora de cosecha de la droga. Rev Cuba Plantas Med. 2001;6(3):98–104.spa
dc.relation.referencesBent S. Herbal medicine in the United States: Review of efficacy, safety, and regulation - Grand Rounds at University of California, San Francisco Medical Center. J Gen Intern Med. 2008;23(6):854–859.spa
dc.relation.referencesKhadra I, Zhou Z, Dunn C, Wilson CG, Halbert G. Statistical investigation of simulated intestinal fluid composition on the equilibrium solubility of biopharmaceutics classification system class II drugs. Eur J Pharm Sci. 2015;67:65–75.spa
dc.relation.referencesMinisterio Salud y Protección Social. Decreto 1156 de 2018. Colombia. 06 de Julio de 2018; 2018:1–25.spa
dc.relation.referencesPresidencia de la República de Colombia. Decreto 549 de 2001. Colombia. 29 de marzo de 2001; 2001:1–24.spa
dc.relation.referencesModesti G. "Estudo químico de espécies brasileiras e Colombianas do Genero Passiflora" Tesis Doctorado. Universidad Federal de Santa Catarina; 2013:45-85.spa
dc.relation.referencesEcheverry SM, Medina HI, Costa GM, Aragón DM. Optimization of flavonoid extraction from Passiflora quadrangularis leaves with sedative activity and evaluation of its stability under stress conditions. Rev. bras. farmacogn. 2018;28(5):610–617.spa
dc.relation.referencesRowe R. Sorbitol. Handbook of Pharmaceutical Excipients. Press P. Sixth Edit. 2009:679–681.spa
dc.relation.referencesRowe R. Glycerin. Handbook of Pharmaceutical Excipients. Press P. Sixth Edit. 2009:284–286.spa
dc.relation.referencesMarkham KR. Techniques of Flavonoids Identification. Academic P. Londres; 1982.spa
dc.relation.referencesChopin J, Bouillant M, Bess E. C-Glycosyl flavonoids. The Flavonoids Advances in Research. 1982:449–498.spa
dc.relation.referencesPatras A. Stability and color evaluation of red cabbage waste hydroethanolic extract in presence of different food additives or ingredients. Food Chem. 2019;275:539–548.spa
dc.relation.referencesJiang T, Mao Y, Sui L, Yang N, Li S, Zhu Z, et al. Degradation of anthocyanins and polymeric color formation during heat treatment of purple sweet potato extract at different pH. Food Chem. 2019;274:460–70.spa
dc.relation.referencesLoutit TS, Keigwin LD. Heat Stability of Strawberry Anthocyanins in Model Solutions Containing Natural Copigments Extracted from Rose (Rosa damascena Mill.) Petals. Nature. 1982;300(5):163–166.spa
dc.relation.referencesOrtmann CF. "Avaliação da estabilidade de extratos, frações e flavonoides C-glicosídeos presentes em Cecropia glaziovii" Tesis de Maestría. Universidad Federal de Santa Catarina; 2013:45-56.spa
dc.relation.referencesCastañeda A, Pacheco MDL, Páez ME, Rodríguez JA, Galán CA. Chemical studies of anthocyanins: A review. Food Chem. 2009;113(4):859–871.spa
dc.relation.referencesLoh ZH, Samanta AK, Sia Heng PW. Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian J. Pharm. 2014;10(4):255–274.spa
dc.relation.referencesChen X, Fadda HM, Aburub A, Mishra D, Pinal R. Cosolvency approach for assessing the solubility of drugs in poly(vinylpyrrolidone). Int J Pharm. 2015;494(1):346–356.spa
dc.relation.referencesMunin A, Edwards-Lévy F. Encapsulation of natural polyphenolic compounds; a review. Pharmaceutics. 2011;3:793–829.spa
dc.relation.referencesDegani L, Gulmini M, Piccablotto G, Iacomussi P, Gastaldi D, Dal Bello F, et al. Stability of natural dyes under light emitting diode lamps. J Cult Herit. 2017;26:12–21.spa
dc.relation.referencesRice-evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham JB. The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic Res. 1995;22(4):375–83.spa
dc.relation.referencesMajer P, Neugart S, Krumbein A, Schreiner M, Hideg É. Singlet oxygen scavenging by leaf flavonoids contributes to sunlight acclimation in Tilia platyphyllos. Environ Exp Bot. 2014;100:1–9.spa
dc.relation.referencesMin DB, Boff JM. Chemistry and reaction of singlet oxygen in foods. Compr Rev Food. 2002;1(2):58–72.spa
dc.relation.referencesHajimohammadi M, Nosrati P. Scavenging effect of pasipay (Passiflora incarnata L.) on singlet oxygen generation and fatty acid photooxygenation. Food Sci Nutr. 2018;6(6):1670–1675.spa
dc.relation.referencesOsorio C, Duque C, Fujimoto Y. El aroma de la badea (Passiflora quadrangularis): Composición y generación de compuestos volatiles a partir de glicósidos, fosfatos y monoterpenos oxigenados.Badea. 2005:107–131.spa
dc.relation.referencesOrsini F, Pellizzoni F, Ricca G, Verotta L. Triterpene glycosides related to quadranguloside from Passiflora quadrangularis. Phytochemistry. 1987;26(4):1101–1105.spa
dc.relation.referencesMachado H, Nagem T, Peters VM, Fonseca CS, Oliveira TT de. Flavonoids and potential therapeutic. Arch. Biochem. Biophys. 2008;27(1):33–39.spa
dc.relation.referencesSiebra AL, Oliveira LR, Martins AOBPB, Siebra DC, Lemos ICS, et al. Potentiation of antibiotic activity by Passiflora cincinnata Mast. front of strains Staphylococcus aureus and Escherichia coli. Saudi J Biol Sci. 2018;25(1):37–43.spa
dc.relation.referencesMunro M, Albertson G, Perry N, Blunt J, Walker J, Cole A. 4-Hydroxy-2-cyclopentenone: An Anti-Pseudomonas and Cytotoxic Component from Passiflora tetrandra. Planta Med. 2007;57(2):129–31.spa
dc.relation.referencesDzotam JK, Touani FK, Kuete V. Antibacterial and antibiotic-modifying activities of three food plants (Xanthosoma mafaffa Lam., Moringa oleifera (L.) Schott and Passiflora edulis Sims) against multidrug-resistant (MDR) Gram-negative bacteria. BMC Complement Altern Med. 2016;16(1):1–8.spa
dc.relation.referencesPelegrini PB, Noronha EF, Muniz MAR, Vasconcelos IM, Chiarello MD, Oliveira JTA, et al. An antifungal peptide from passion fruit (Passiflora edulis) seeds with similarities to 2S albumin proteins. Biochim Biophys Acta. 2006;1764(6):1141–1146.spa
dc.relation.referencesAgizzio AP, Carvalho AO, Ribeiro S de FF, Machado OLT, Alves EW, Okorokov LA, et al. A 2S albumin-homologous protein from passion fruit seeds inhibits the fungal growth and acidification of the medium by Fusarium oxysporum. Arch Biochem Biophys. 2003;416(2):188–195.spa
dc.relation.referencesCarvalho O, Anto M, Da M, Ribeiro SFF, Gomes VM. The antifungal properties of a 2S albumin-homologous protein from passion fruit seeds involve plasma membrane permeabilization and ultrastructural alterations in yeast cells. Plant Sci. 2006;171:515–522.spa
dc.rightsDerechos reservados - Universidad Nacional de Colombiaspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.licenseAtribución-NoComercial 4.0 Internacionalspa
dc.rights.spaAcceso abiertospa
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/spa
dc.subject.ddcCiencias naturales y matemáticasspa
dc.subject.ddcQuímica y ciencias afinesspa
dc.subject.ddcPlantasspa
dc.subject.ddcMedicina y saludspa
dc.subject.proposalQuality by designeng
dc.subject.proposalCalidad basada en el diseñospa
dc.subject.proposalPassiflora quadrangulariseng
dc.subject.proposalPassiflora quadrangularisspa
dc.subject.proposalFormulaciónspa
dc.subject.proposalRisk managementeng
dc.subject.proposalGestión del riesgospa
dc.subject.proposalFormulationeng
dc.subject.proposalHerbal producteng
dc.subject.proposalExtracto naturalspa
dc.titleContribución al desarrollo de una formulación líquida de administración oral para un extracto de hojas de Passiflora quadrangularis L aplicando los conceptos del enfoque de calidad basada en el diseño (QbD)spa
dc.typeTrabajo de grado - Maestríaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdccspa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/masterThesisspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2spa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Tesis Final.pdf
Tamaño:
2.74 MB
Formato:
Adobe Portable Document Format

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
3.9 KB
Formato:
Item-specific license agreed upon to submission
Descripción: